Zoetis IPO launches at $2.2bn
1 February 2013 Business
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
Pharma giant Pfizer has taken the first steps towards spinning off its animal health business. It has been announced that preparations are underway to file for a potential stock market launch of the new firm. The standalone company name – Zoetis – was announced at the same time.
Pfizer’s animal health business has 9000 employees and markets products in over 120 different countries. In 2011, it generated sales of about $4.2 billion (£2.7 billion).
Zoetis is expected to start trading in July 2013. The company plans to give further details as part of its second quarter profit announcement.
1 February 2013 Business
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
15 May 2013 Research
The environmental legacy of salvaging gold from electronic waste can be dramatically cut using corn starch instead of cyanide
14 May 2013 News and Analysis
Government plans to turn scientific body into a 'tool for industry' leading to fears basic research will be sidelined
13 May 2013 Research
Engineered protein can be used to produce antivenoms and might provide long-lasting protection against bites
17 May 2013 Research
Seamless integration of electronics and tissue could be used with other artificial implants and synthetic organs